You’ve probably heard the advice “Buy the dip” before. Or as Warren Buffet famously said, “Buy when there’s blood in the streets.” Generally speaking, that’s sound advice. But where it often fails is when the market is moving up...
Kiora Pharmaceuticals CEO Brian Strem joined Steve Darling from Proactive to share news the company’s plan to broaden the clinical development of KIO-301, a treatment designed for various inherited retinal diseases. The...
Silver Wolf Exploration President Peter Latta joined Steve Darling from Proactive to share news about the recent milestone achieved by the company — the acquisition of an exploration diamond drilling permit for the “El...
MTL Cannabis CEO Mike Perron joined Steve Darling from Proactive to to discuss the ethos and operations of their family-founded company, which places a high value on the quality and potential of the cannabis plant. The...
Japan Gold CEO John Proust joined Steve Darling from Proactive to to announce significant developments in the company’s mineral exploration initiatives. The company has seen substantial results from in-fill sampling in a...
AMSC CEO Pal Magnussen joined Steve Darling from the Proactive studio at the OTC in New York to discuss the company’s transition and investment focus. Formerly known as the American Shipping Company, AMSC sold its entire...
CMC Markets PLC (LSE:CMCX) chief financial officer Albert Soleiman speaks to Thomas Warner from Proactive London after the UK-based financial services company released half-year results for the period ended 30 September. CMC...
In an exclusive interview with Dr Huma Qamar, chief scientific officer for Medicus Pharma Ltd, exciting developments in skincare and oncology are discussed. Dr Qamar shares her passion for addressing unmet medical needs,...
Sigma Lithium Corp’s CEO, Ana Cabral-Gardner, shared exciting news in a recent interview with Thomas Warner from Proactive. The company reported a 35% net profit margin in its first operational quarter, showcasing...
Galliford Try Holdings PLC (LSE:GFRD) chief financial officer Andrew Duxbury speaks to Thomas Warner from Proactive about recent progress with the Sustainable Growth Strategy that the UK construction group first embarked on back...
Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share insights on the company’s focus on innovative drug formulation technology after reporting strong third-quarter results. With three growing...
Wishpond Technologies CEO Ali Tajskandar and CFO David Pais joined Steve Darling from Proactive to present the company’s financial achievements for the third quarter and the first nine months of 2023. Wishpond reported a rise in...
Arecor Therapeutics PLC CEO Sarah Howell speaks to Thomas Warner from Proactive after the biopharmaceutical group announced the first commercial sale of a product that incorporates its proprietary Arestat technology, known as...
